Top Markets
#1 EXOD EXOD +56.80%
#2 Cysic Cysic +13.33%
#3 Bedrock Bedrock +8.66%
#4 Fabric Protocol Fabric Protocol +7.70%
#5 Cap Cap +5.10%
#6 Perle Perle +4.46%
#7 Dual Dual +3.60%
#8 The Black Bull The Black Bull +3.49%
#9 Figure Heloc Figure Heloc +3.49%
#10 Collector Crypt Collector Crypt +3.28%
Coin of the day
EXOD EXOD
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Classificação em ações #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Preço da ação
$0.1
Última sincronização: 2024-06-18
Valor de mercado
$1.31M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Pascal Biosciences Inc. (PSCBF)

Categoria

Healthcare
Margem Operacional de Pascal Biosciences Inc. (PSCBF)
Margem Operacional em August 2026 TTM: -133.68%
De acordo com os relatórios financeiros mais recentes e o preço das ações da Pascal Biosciences Inc., a margem operacional atual (TTM) é -133.68%. No final de 2022, a margem operacional era 0.00%.
Histórico da Margem Operacional da Pascal Biosciences Inc. de 2019 a 2026
Margem Operacional no final de cada ano
Ano Margem Operacional Alterar
2026 (TTM) -133.68% 0.00%
2023 -133.68% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Margem Operacional de empresas semelhantes ou concorrentes
Empresa Margem Operacional Diferença na Margem Operacional País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -100.29%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.23%
BE
O que é a Margem Operacional de uma empresa?
A Margem Operacional é um indicador essencial para avaliar a rentabilidade de uma empresa. Margens operacionais mais altas geralmente são melhores, pois mostram que uma empresa consegue vender seus produtos ou serviços por muito mais do que o custo de produzi-los. É calculada dividindo os lucros da empresa pela sua receita.